Clinical Trials Update: Sept. 28, 2009
Epilepsy Gout Attacks Migraine
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This is study is for people aged 18 to 60 who have epilepsy. To qualify, you must be taking a stable dose of Dilantin (phenytoin).
The research site is in San Antonio, Texas.
This study will evaluate an investigational drug for preventing acute gout flares. To qualify, you must be aged 18 to 80.
The research site is in DeLand, Fla.
This study will test an investigational drug for migraines. Candidates must be aged 18 to 65 and have at least one migraine per month.
The research site is in Kenosha, Wisc.
Copyright 2009ClinicalConnection.com. All rights reserved.